Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans
Kirti S. Prabhu(Hamad Medical Corporation), Shahab Uddin(King Faisal Specialist Hospital & Research Centre)
Cited by 15
Related Papers
Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival
|Blood|2006|258
Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
|American Journal Of Pathology|2011|155
Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis
|PLoS ONE|2012|152
Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer
|Molecular Cancer|2009|123